Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Crinetics Pharmaceuticals, Inc. | crnx-10k_20191231.htm |
| EX-32.1 - EX-32.1 - Crinetics Pharmaceuticals, Inc. | crnx-ex321_8.htm |
| EX-31.2 - EX-31.2 - Crinetics Pharmaceuticals, Inc. | crnx-ex312_6.htm |
| EX-31.1 - EX-31.1 - Crinetics Pharmaceuticals, Inc. | crnx-ex311_10.htm |
| EX-23.1 - EX-23.1 - Crinetics Pharmaceuticals, Inc. | crnx-ex231_7.htm |
| EX-4.3 - EX-4.3 - Crinetics Pharmaceuticals, Inc. | crnx-ex43_1104.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Crinetics Pharmaceuticals, Inc. (the “Company”) hereby certifies, to his knowledge, that:
(i) the accompanying Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
/s/ Marc J.S. Wilson |
|
Marc J.S. Wilson |
|
Chief Financial Officer |
Date: March 9, 2020
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.